No results found
Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
Five decades of EMBL visits
Structural biologist Shlomo Trachtenberg has made research trips to EMBL from Israel since the late 1970s and reflects on the boost EMBL’s technology provided his research, the ingredients for an ideal research institution, and his ongoing fascination with microscopes.
CONNECTIONSLAB MATTERS2023
connectionslab-matters
Toadlet peptide transforms into a deadly weapon against bacteria
Researchers at the Technion – Israel Institute of Technology and EMBL Hamburg, in collaboration with scientists in Israel and Spain, have discovered remarkable molecular properties of an antimicrobial peptide from the skin of the Australian toadlet. The discovery could inspire the development of…
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Welcome: Meytal Landau
New associate group leader at EMBL Hamburg investigates the structure of functional amyloids in bacteria and in human disease
LAB MATTERSPEOPLE & PERSPECTIVES2020
lab-matterspeople-perspectives
Meytal Landau: a visiting researcher in Hamburg
Strengthening ties between EMBL and Israel through the Scientific Visitor Programme
PEOPLE & PERSPECTIVES2020
people-perspectivesscience
Integrating imaging research across Europe
Euro-BioImaging now established as a European Research Infrastructure Consortium
CONNECTIONSLAB MATTERS2019
connectionslab-matters
Guiding young scientists
17 young scientists experienced hands-on training at EMBL Hamburg.
CONNECTIONS2018
connectionsevents